New Ray Medicine International Holding Overview
- Founded
- 2001
- Status
- Public
- Employees
- 33
- Stock Symbol
- 06108
- Investments
- 1
- Share Price
- $0.05
- (As of Wednesday Closing)
New Ray Medicine International Holding General Information
Description
New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.
Contact Information
Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
- Room 517, 5th Floor, Town Health Technology Centre
- 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, New Territories
- Hong Kong
- Hong Kong
+852 2210 0000
New Ray Medicine International Holding Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $0.06 | $0.03 - $0.11 | $91M | 1.67B | 10.2M | -$0.01 |
New Ray Medicine International Holding Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 80,570 | 79,831 | 77,639 | 75,110 |
| Revenue | 17,010 | 15,140 | 47,518 | 30,188 |
| EBITDA | (8,978) | (5,148) | 5,420 | (11,626) |
| Net Income | (9,332) | (5,629) | 4,236 | (13,475) |
| Total Assets | 79,204 | 87,167 | 98,061 | 106,281 |
| Total Debt | 315 | 280 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
New Ray Medicine International Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.
Request a free trialNew Ray Medicine International Holding Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Linxing He | Director of Subsidiaries of the Company | ||
| Lee Yuet | Executive Director | ||
| Yang Fang | Executive Director |
New Ray Medicine International Holding Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNew Ray Medicine International Holding Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.
Request a free trialNew Ray Medicine International Holding Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000 000000 | 10-Apr-2017 | 000000000 00000000 | 000.00 | Asset Management |